107 related articles for article (PubMed ID: 1168860)
1. Some behavioural signs of morphine withdrawal blocked by condition stimuli.
Tye NC; Iversen SD
Nature; 1975 May; 255(5507):416-8. PubMed ID: 1168860
[No Abstract] [Full Text] [Related]
2. FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
Manwell LA; Satvat E; Lang ST; Allen CP; Leri F; Parker LA
Pharmacol Biochem Behav; 2009 Nov; 94(1):154-62. PubMed ID: 19698735
[TBL] [Abstract][Full Text] [Related]
3. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
4. [Activity of naloxone and naltrexone on the development of the morphine withdrawal syndrome].
Piccinelli D; de Feo G; Mazzanti G
Boll Soc Ital Biol Sper; 1986 Oct; 62(10):1221-8. PubMed ID: 3828120
[No Abstract] [Full Text] [Related]
5. The behavioral effects of chlorpromazine alone and in combination with different morphine treatments in rats.
Lucot JB; McMillan DE; Leander JD
J Pharmacol Exp Ther; 1979 Jan; 208(1):67-72. PubMed ID: 569698
[No Abstract] [Full Text] [Related]
6. Alleviation of narcotic withdrawal syndrome by conditional stimuli.
Lal H; Miksic S; Drawbaugh R; Numan R; Smith N
Pavlov J Biol Sci; 1976; 11(4):251-62. PubMed ID: 1033508
[TBL] [Abstract][Full Text] [Related]
7. The behavioral effects of d-amphetamine alone and in combination with acute and chronic morphine treatments in rats.
Lucot JB; McMillan DE; Leander JD
J Pharmacol Exp Ther; 1979 Aug; 210(2):158-65. PubMed ID: 572418
[No Abstract] [Full Text] [Related]
8. Differential classical conditioning of abstinence syndrome in morphine-dependent rats.
Trost RC
Psychopharmacologia; 1973 May; 30(2):153-61. PubMed ID: 4736404
[No Abstract] [Full Text] [Related]
9. Role of withdrawal in reinstatement of morphine-conditioned place preference.
Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
[TBL] [Abstract][Full Text] [Related]
10. An analysis of 70 years of morphine classical conditioning: implications for clinical treatment of narcotic addition.
Lynch JJ; Stein EA; Fertziger AP
J Nerv Ment Dis; 1976 Jul; 163(1):47-58. PubMed ID: 932711
[TBL] [Abstract][Full Text] [Related]
11. Quasi morphine-abstinence syndrome.
Collier HO; Francis DL; Henderson G; Schneider C
Nature; 1974 May; 249(456):471-3. PubMed ID: 4545823
[No Abstract] [Full Text] [Related]
12. Clonidine and naloxone-induced opiate withdrawal: a comparison between clonidine and morphine in man.
Fantozzi R; Luciani G; Masini E; Blandina P; Mannaioni P
Subst Alcohol Actions Misuse; 1980; 1(4):369-73. PubMed ID: 7302789
[No Abstract] [Full Text] [Related]
13. Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and "relapse" in morphine-addicted rats.
Wikler A; Pescor FT
Psychopharmacologia; 1967; 10(3):255-84. PubMed ID: 5626647
[No Abstract] [Full Text] [Related]
14. Morphine dependence in rats: secondary reinforcement from environmental stimuli.
Kumar R
Psychopharmacologia; 1972; 25(4):332-8. PubMed ID: 5065795
[No Abstract] [Full Text] [Related]
15. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
He S; Grasing K
Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368
[TBL] [Abstract][Full Text] [Related]
16. The consummatory and motivational behaviors for natural rewards following long-term withdrawal from morphine: no anhedonia but persistent maladaptive behaviors for high-value rewards.
Li Y; Zheng X; Xu N; Zhang Y; Liu Z; Bai Y
Psychopharmacology (Berl); 2017 Apr; 234(8):1277-1292. PubMed ID: 28229178
[TBL] [Abstract][Full Text] [Related]
17. Lesions of the medial prefrontal cortex prevent the acquisition but not reinstatement of morphine-induced conditioned place preference in mice.
Hao Y; Yang J; Sun J; Qi J; Dong Y; Wu CF
Neurosci Lett; 2008 Mar; 433(1):48-53. PubMed ID: 18243552
[TBL] [Abstract][Full Text] [Related]
18. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
Cervo L; Romandini S; Samanin R
Br J Pharmacol; 1983 Aug; 79(4):993-6. PubMed ID: 6686075
[TBL] [Abstract][Full Text] [Related]
19. Pleiotrophin modulates morphine withdrawal but has no effects on morphine-conditioned place preference.
Gramage E; Vicente-Rodríguez M; Herradón G
Neurosci Lett; 2015 Sep; 604():75-9. PubMed ID: 26222257
[TBL] [Abstract][Full Text] [Related]
20. Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence.
Cicero TJ; Meyer ER
J Pharmacol Exp Ther; 1973 Feb; 184(2):404-8. PubMed ID: 4734581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
